**Breakthrough Properties Secures $430 Million in First Closing of Second Life Science Fund**
Breakthrough Properties, a joint venture between Tishman Speyer and Bellco Capital, has announced the first closing of its second life sciences investment fund, Breakthrough Properties Growth Portfolio II, securing $430 million. The fund aims to invest in a diversified portfolio of life science assets across key innovation clusters in the United States and Europe.
This latest fund follows the success of the company’s inaugural investment vehicle, which closed at $3 billion in 2022. Continuing its strategy, the new fund will focus on acquiring and developing properties in leading biotech and research hubs.
The initial round of funding drew strong interest from a wide range of institutional and private investors, including global asset managers, investment advisors, pension funds, and family offices. Breakthrough Properties plans to hold additional closings through 2026.
“This closing aligns with the most compelling investment window we’ve seen in years,” said Breakthrough CEO Dan Belldegrun. “Transitory market dynamics have generated the opportunity to acquire high-quality assets at heavily disrupted pricing and to capitalize on the sector’s long-term structural tailwinds. The incredible power of science is only accelerating, generalist investors are retreating, and new supply is entirely shut off. We believe these are precisely the ingredients for a fantastic investment vintage.”
Breakthrough Properties continues to position itself at the forefront of the life sciences real estate sector, leveraging scientific innovation and real estate development expertise to meet growing demand for research and lab space globally.
